Repligen Corporation

Repligen Corporation company information, Employees & Contact Information

FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to prospective job applicants using fraudulent email addresses. All legitimate communications from Repligen will be sent from an individual with an email address ending in @repligen.com. If you have any concerns that a communication may be fraudulent and you would like to confirm whether it is, you may email legal@repligen.com and someone will respond. Repligen is a bioprocessing-focused life sciences company bringing over 40 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies. Repligen headquarters is in Waltham, Massachusetts and our manufacturing facilities are located around the world. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.
Looking for a particular Repligen Corporation employee's phone or email?

Repligen Corporation Questions

News

Repligen to Report Third Quarter 2025 Financial Results - GlobeNewswire

Repligen to Report Third Quarter 2025 Financial Results GlobeNewswire

Repligen Corporation to Announce Third Quarter 2025 Financial Results on October 28 - Quiver Quantitative

Repligen Corporation to Announce Third Quarter 2025 Financial Results on October 28 Quiver Quantitative

Oct 28 Webcast: Repligen to Report Third Quarter Results; Conference Call 8:30 a.m. ET - Stock Titan

Oct 28 Webcast: Repligen to Report Third Quarter Results; Conference Call 8:30 a.m. ET Stock Titan

Repligen Corporation to Announce Second Quarter 2025 Financial Results on July 29 - Quiver Quantitative

Repligen Corporation to Announce Second Quarter 2025 Financial Results on July 29 Quiver Quantitative

Bioprocessing Leader Repligen Lines Up Three Major Healthcare Conference Presentations in September 2025 - Stock Titan

Bioprocessing Leader Repligen Lines Up Three Major Healthcare Conference Presentations in September 2025 Stock Titan

Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization - GlobeNewswire

Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization GlobeNewswire

Repligen Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance

Repligen Reports Fourth Quarter and Full Year 2024 Financial Results Yahoo Finance

Repligen Sets Q2 2025 Earnings Date: Key Financial Results Coming July 29 - Stock Titan

Repligen Sets Q2 2025 Earnings Date: Key Financial Results Coming July 29 Stock Titan

Repligen Corporation Acquires Desktop Bioprocessing Devices from 908 Devices Inc. for $70 Million - Quiver Quantitative

Repligen Corporation Acquires Desktop Bioprocessing Devices from 908 Devices Inc. for $70 Million Quiver Quantitative

Repligen Corporation Launches CTech™ SoloVPE® PLUS System for Enhanced UV-Based Bioprocessing Analytics - Quiver Quantitative

Repligen Corporation Launches CTech™ SoloVPE® PLUS System for Enhanced UV-Based Bioprocessing Analytics Quiver Quantitative

Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance - GlobeNewswire

Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance GlobeNewswire

Repligen Corporation Launches AVIPure® dsRNA Clear OPUS® Columns to Enhance mRNA Therapeutics Production - Quiver Quantitative

Repligen Corporation Launches AVIPure® dsRNA Clear OPUS® Columns to Enhance mRNA Therapeutics Production Quiver Quantitative

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns - GlobeNewswire

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns GlobeNewswire

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance - Yahoo

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance Yahoo

Repligen Corporation to Present at Wells Fargo Healthcare Conference - Yahoo Finance

Repligen Corporation to Present at Wells Fargo Healthcare Conference Yahoo Finance

Repligen Appoints Olivier Loeillot as CEO - citybiz

Repligen Appoints Olivier Loeillot as CEO citybiz

Repligen Opens Training & Innovation Center to Elevate Customer Experience - GlobeNewswire

Repligen Opens Training & Innovation Center to Elevate Customer Experience GlobeNewswire

Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer - Yahoo Finance

Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer Yahoo Finance

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti - GlobeNewswire

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti GlobeNewswire

Repligen Appoints Jason K. Garland as Chief Financial Officer - citybiz

Repligen Appoints Jason K. Garland as Chief Financial Officer citybiz

Repligen Announces Private Convertible Transaction of $600 - GlobeNewswire

Repligen Announces Private Convertible Transaction of $600 GlobeNewswire

Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova - GlobeNewswire

Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova GlobeNewswire

Repligen Appoints Martin D. Madaus to Board of Directors - citybiz

Repligen Appoints Martin D. Madaus to Board of Directors citybiz

Repligen Announces Agreement to Acquire Avitide Inc. - GlobeNewswire

Repligen Announces Agreement to Acquire Avitide Inc. GlobeNewswire

Repligen Corporation set to significantly expand bioprocessing manufacturing capacity and create 130 - IDA Ireland

Repligen Corporation set to significantly expand bioprocessing manufacturing capacity and create 130 IDA Ireland

Downstream Bottlenecks are Slowing mAbs Manufacturing: This New TFF Tech Can Help - Genetic Engineering and Biotechnology News

Downstream Bottlenecks are Slowing mAbs Manufacturing: This New TFF Tech Can Help Genetic Engineering and Biotechnology News

Increased Productivity and Seamless Scalability: Advantages of an ATF System for Upstream Process Intensification - BioProcess International

Increased Productivity and Seamless Scalability: Advantages of an ATF System for Upstream Process Intensification BioProcess International

Repligen Announces Agreement to Acquire Engineered Molding Technology - GlobeNewswire

Repligen Announces Agreement to Acquire Engineered Molding Technology GlobeNewswire

Repligen Corporation Announces Agreement to Acquire - GlobeNewswire

Repligen Corporation Announces Agreement to Acquire GlobeNewswire

Repligen Corporation Announces Agreement to Acquire Process - GlobeNewswire

Repligen Corporation Announces Agreement to Acquire Process GlobeNewswire

Repligen Corporation and Spectrum, Inc. to Join Forces - GlobeNewswire

Repligen Corporation and Spectrum, Inc. to Join Forces GlobeNewswire

Repligen Now a Bioprocess Product Firm - Genetic Engineering and Biotechnology News

Repligen Now a Bioprocess Product Firm Genetic Engineering and Biotechnology News

Repligen Announces Market Launch of OPUS® 80R, Reinforces - GlobeNewswire

Repligen Announces Market Launch of OPUS® 80R, Reinforces GlobeNewswire

Reducing Clinical-Phase Manufacturing Costs: Collaborating for Savings without Compromising Quality or Performance - BioProcess International

Reducing Clinical-Phase Manufacturing Costs: Collaborating for Savings without Compromising Quality or Performance BioProcess International

Top Repligen Corporation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant